Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Jos J. Jager"'
Autor:
Fred van der Ent, Suprapto H. Sastrowijoto, Ruud Houben, Bianca Hanbeukers, Piet van den Ende, Liesbeth J. Boersma, Lars H.P. Murrer, Kristien Keymeulen, Koen Van de Vijver, Jos J. Jager, Jacques Borger
Publikováno v:
International Journal of Radiation Oncology Biology Physics, 75(3), 757-63. Elsevier Science
PURPOSE: To determine the difference in size between computed tomography (CT)-based irradiated boost volumes and simulator-based irradiated volumes in patients treated with breast-conserving therapy and to analyze whether the use of anisotropic three
Autor:
Dominic A.X. Schinagl, Harry Bartelink, Henk Struikmans, C.C. Wárlám-Rodenhuis, Françoise Collin, Walter Van den Bogaert, Jos J. Jager, Augustinus A. M. Hart, Alain Fourquet, Philip Poortmans, Heather A. Jones, Jean-Claude Horiot, S. Bing Oei, Johannes L. Peterse, Ninja Antonini, Laurence Collette
Publikováno v:
Journal of Clinical Oncology, 27, 30, pp. 4939-47
Journal of Clinical Oncology, 27(30), 4939-4947. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 27, 4939-47
Journal of Clinical Oncology, 27(30), 4939-4947. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 27, 4939-47
Purpose To investigate the long-term impact of pathologic characteristics and an extra boost dose of 16 Gy on local relapse, for stage I and II invasive breast cancer patients treated with breast conserving therapy (BCT). Patients and Methods In the
Autor:
Sandra, Collette, Laurence, Collette, Tom, Budiharto, Jean-Claude, Horiot, Philip M, Poortmans, Henk, Struikmans, Walter, Van den Bogaert, Alain, Fourquet, Jos J, Jager, Willem, Hoogenraad, Rolf-Peter, Mueller, John, Kurtz, David A L, Morgan, Jean-Bernard, Dubois, Emile, Salamon, Rene, Mirimanoff, Michel, Bolla, Marleen, Van der Hulst, Carla C, Wárlám-Rodenhuis, Harry, Bartelink, J, Borger
Publikováno v:
European Journal of Cancer, 44(17), 2587-2599. ELSEVIER SCI LTD
European Journal of Cancer, 44, 17, pp. 2587-99
European Journal of Cancer, 44, 2587-99
European Journal of Cancer, 44, 17, pp. 2587-99
European Journal of Cancer, 44, 2587-99
Contains fulltext : 71420.pdf (Publisher’s version ) (Closed access) The EORTC 22881-10882 trial in 5178 conservatively treated early breast cancer patients showed that a 16 Gy boost dose significantly improved local control, but increased the risk
Autor:
Marianne Pierart, Laurence Collette, H. Struikmans, Jean-Claude Horiot, R.P. Muller, M. van der Hulst, Harry Bartelink, Jean-Bernard Dubois, Alain Fourquet, P.M. Poortmans, C.C. Wárlám-Rodenhuis, M. Bolla, W.J. Hoogenraad, W. Van den Bogaert, Jos J. Jager
Publikováno v:
Cancer Radiotherapie, 12, 565-70
Cancer Radiotherapie, 12, 6-7, pp. 565-70
Cancer Radiotherapie, 12, 6-7, pp. 565-70
But. - Etudier l'impact du complement d'irradiation du lit tumoral dans le cadre du traitement conservateur sur le controle local, le resultat cosmetique, la fibrose et la survie globale chez des patientes atteintes de cancer du sein de petit stade.
Autor:
Philip Poortmans, Alain Fourquet, Laurence Collette, S. Bing Oei, C.C. Wárlám-Rodenhuis, W.J. Hoogenraad, Harry Bartelink, Henk Struikmans, Jean-Claude Horiot, Marianne Pierart, Jos J. Jager, Walter Van den Bogaert
Publikováno v:
Journal of Clinical Oncology, 25, 22, pp. 3259-65
Journal of Clinical Oncology, 25, 3259-65
Journal of Clinical Oncology, 25, 3259-65
Purpose To investigate the long-term impact of a boost radiation dose of 16 Gy on local control, fibrosis, and overall survival for patients with stage I and II breast cancer who underwent breast-conserving therapy. Patients and Methods A total of 5,
Publikováno v:
European Journal of Cancer. 38:667-673
A randomised phase II trial was initiated to explore the feasibility of concomitant cisplatin and radiotherapy with conventional fractionation (CF) or multiple fractions per day (MFD) for patients with locally advanced head and neck malignancies. The
Publikováno v:
APOPTOSIS. 7:361-365
Currently, the mainly used characteristics to predict outcome or treatment response in patients with breast cancer are tumor size, N-status, histological grade and receptor status (ER/PgR). However, these conventional clinico-pathological characteris
Autor:
Liesbeth J. Boersma, Tim Lustberg, Patricia J.A.M. Brouwers, Angela van Baardwijk, Bart Reymen, Lars H.P. Murrer, Judith van Loon, Jacques Borger, Sebastian M.J.J.G. Nijsten, Jos J. Jager
Publikováno v:
Practical radiation oncology, 5(3), e135-e141. Elsevier Science
Purpose: To compare set-up and 2-dimensional (2D) electronic portal imaging device (EPID) dosimetry data of breast cancer patients treated during voluntary moderately deep inspiration breath hold (vmDIBH) and free breathing (FB). Methods and material
Autor:
L. Verheesen, Jaap D. Zindler, Jos J. Jager, S. van der Meer, N. Menten, Daniëlle B.P. Eekers, Geert Bosmans, L.H.P. Murrer
Publikováno v:
Radiotherapy and Oncology. 115:S819-S820
Autor:
F. B. J. M. Thunnissen, W. David George, Martijn Poeze, Johannes L. Peterse, Maarten F. von Meyenfeldt, Jos M.A. de Jong, Jos J. Jager
Publikováno v:
Journal of Pathology, 185(1), 32-37. Wiley
Department of Surgery, University Hospital Maastricht, The Netherlands.Radiation used in breast-conserving therapy (BCT) for early breast cancer, to eradicate residual malignant cells after tumour resection, induces DNA damage and cell death. Little